Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion

Surgery

Volumn 127, Issue 2, 2000, Pages 142-147

  Shamamian, Peter ^a,b,c   Pocock, Ben J Z ^a,b   Schwartz, Jess D ^a,b   Monea, Sara ^a,b   Chuang, Neal ^a,b   Whiting, David ^a,b   Marcus, Stuart G ^a,b   Galloway, Aubrey C ^a,b   Mignatti, Paolo ^a,b  

^a Department of Pathology   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BATIMASTAT; CATHEPSIN G; COLLAGENASE; ELASTASE; GELATINASE A; PROTEINASE; SERINE PROTEINASE;

ARTICLE; CANCER INVASION; CARCINOGENESIS; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PURIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL;

EID: 0033953908     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.101155     Document Type: Article

References (24)

1. 1. Mignatti P, Rifkin DB. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993;73:161-95.
2. 2. Kleiner DE, Stetler-Stevenson WG. Structural biochemistry and activation of matrix metalloproteinases. Curr Opin Cell Biol 1993;5:891-7.
3. 3. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-5.
4. 4. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG. Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991;266:7870-5.
5. 5. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. J Biol Chem 1995;270:5872-6.
6. 6. Strongin AY, Marmer BL, Grant GA, Goldberg GI. Plasma membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 1993;268:14033-9.
7. 7. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumors. Nature 1994;370:61-5.
8. 8. Okada Y, Belloq JP, Rouyer N, Chenard MP, Rio MC, Chambon P, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995;92:2730-4.
9. 9. Tokurako M, Sata H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72 kDa Type IV collagenase/MMP-2 in lung carcinoma correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995;64:355-9.
10. 10. Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, et al. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996;65:209-13.
11. 11. Cao J, Sato H, Takino T, Seiki M. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 1995;270:801-5.
12. 12. Atkinsons SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, et al. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995;270:30479-85.
13. 13. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem 1995;270:5331-8.
14. 14. Will H, Atkinsons SJ, Butler G, Smith B, Murphy G. The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. J Biol Chem 1996;271:17119-23.
15. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 1990;50:6184-91.
16. 16. Lohi J, Lehti K, Westermark J, Kahari VM, Keski-Oja J. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 1996;239:239-47.
17. 17. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, et al. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell bound reactants. EMBO J 1997; 16:2319-32.
18. 18. Schwartz JD, Monea S, Marcus SG, Patel S, Eng K, Galloway AC, et al. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. J Surg Res 1998;76:79-85.
19. 19. Schwartz JD, Shamamian P, Monea S, Whiting D, Marcus SG, Galloway AC, et al. Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase. Surgery 1998;124:232-8.
20. 20. Monea S, Lehti K, Schwartz J, Shamamian P, Marcus S, Galloway AC, et al. Requirement for plasmin and membrane type I matrix metalloproteinase in the cell surface activation of gelatinase A (MMP-2). [Abstract]. Molec Bio Cell Suppl 1997;8:434.
21. 21. Lee AH, Happerfield LC, Borrow LG, Millis RR. Angiogenesis and inflammation in ductal carcinoma in situ of the breast. J Pathol 1997;181:200-6.
22. 22. Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD. The codependence of angiogenesis and inflammation. FASEB J 1997;11:457-65.
23. 23. Scholl SM, Pallud C, Beuvon K, Hacene K, Stanley ER, Rohrschneider L, et al. Anticolony-stimulating factor-1 antibody staining in primary breast adenocarcinoma correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst 1994;86:120-6.
24. 24. Monea S, Roberts B, Marcus SG, Shamamian P, Mignatti P. Roles of MT1-MMP in the regulation of cell surface proteolysis. Ann NY Acad Sci. In press.